Herbal Medicines for the Treatment of Chronic Obstructive Airway Diseases (Asthma or Chronic Obstructive Pulmonary Disease): A Prospective Observational Study. (29th May 2022)

• Record Type: Journal Article
• Authors: Lyu, Yee Ran; Lee, Su-Won; Kim, Si-Yeon; Han, Hye-Bin; Yang, Won-Kyung; Kim, Seung-Hyung; Jung, In Chul; Kwon, O-jin; Kim, Ae-Ran; Kim, Jinhee; Lee, Mi Young; Park, Yang-Chun
• Other Names: Jin Hualiang Academic Editor.
• Is Part Of: Evidence-based complementary and alternative medicine. Volume 2022(2022)
• Publication Date: 2022-05-29
• Subjects: Alternative medicine -- Periodicals; 615.505
• DOI: 10.1155/2022/3485757
• Languages: English
• ISSNs: 1741-427X

Abstract

Abstract : Background . Obstructive airway disease is a major health problem and has a great impact on global socioeconomic burden. Despite therapeutic advances in recent decades, there is still a need for effective and safe therapeutic agents for patients with asthma or chronic obstructive pulmonary disease (COPD). Methods . This prospective observational study explored the effects of herbal medicines in patients with asthma and COPD. All participants visited the hospital at least every 4 weeks for 12 weeks to receive their herbal medicines based on their pattern identification and to evaluate safety and efficacy endpoints. We followed the diagnostic criteria used by Korean medicine doctors to prescribe herbal medicines, explored variations in prescribed herbal medicines, and explored a number of clinical features in patients with asthma or COPD. Results . A total of 24 patients were enrolled: 14 were diagnosed with asthma and 10 with COPD and 19 completed the study. After 12 weeks of herbal medicine treatment, herbal medicines significantly improved the modified Clinical Asthma Measurement Scale in Oriental Medicine-V in asthma patients and the modified Medical Research Council Dyspnoea Scale and St. George's Respiratory Questionnaire in COPD patients. For all patients, modified Medical Research Council Dyspnoea Scale score and interleukin-13 were found to be significantly different after treatment. Additionally, the majority of patients were satisfied with our herbal medicine treatments, and no severe adverse events were reported during the study. Conclusions . Our study provides preliminary clinical data on the safety and efficacy of herbal medicines in patients with asthma and COPD.